NFX

Why NFX Invested in Pepper Bio: The ‘Waze for Drug Discovery’ Will Treat the Untreatable

Loup Ventures

Gene and Andrew Test Drive Tesla FSD Beta 10.3.1

On XYZ | Caitlin Pintavorn

Constitution DAO: How to Build a DAO in 10 Days

Loup Ventures

Apple Car Would Be In Apple’s Wheelhouse

A Wealth of Common Sense | Ben Carlson

What’s Going to Put an End to the Labor Shortage?

Sparrow One

‘Exclusivity’ in an age of abundance

Ripple Ventures

The Global Deck of Talent Is Reshuffling

Newcomer | Eric Newcomer

Raising More With Less

Movements | Adam Feldman

Chicken Delivery Robots are here

Net Interest | Marc Rubinstein

iBuy, iRent, iLose

7wire Ventures

7wireVentures Named to ChicagoInno’s 50 on Fire List

Ryan Caldbeck | Ryan Caldbeck

Professional Development and What to Do When You Hear “I’m Not Growing as Much as I Want”

Lightspeed Venture Partners

Digital therapeutics — identifying the hurdles and establishing the evidence for transformational…

Clouded Judgement | Jamin Ball

Clouded Judgement 11.19.21

The Diff

Defensive Monopolies

A16Z

The Rise Of Many in Consumer Fintech

Tough Venturing | John Tough

Sales Efficiency Drives Valuation Premiums

This Week in Fintech

This Week in Fintech (11/19)

Climate Tech VC

🌏 Speeding and scaling climate action

Madrona Ventures

Meet the Investor: Aseem Datar

Sequoia Capital

The Rising Consumer Demand for Data Privacy and Autonomy

Jason Stoffer

Chobani S-1

Securities by Lux Capital

Lux Recommends #304: Neural Circuits, Mice Paralysis, and Octopus Intelligence

Tomasz Tunguz

Samsara S-1: How 7 Key Benchmarks Stack Up

Matt Turck

In Conversation with Mark Grover, CEO, Stemma